Inflammatory Bowel Disease (IBD) encompasses two chronic conditions causing long-lasting inflammation in your gastrointestinal (GI) tract: Crohn’s disease and ulcerative colitis. According to the Centers for Disease Control and Prevention (CDC), about 1.3 percent of adults in the United States had IBD in 2015, translating to roughly 3 million people.
Researchers have yet to pinpoint the exact cause of IBD.
However, it's clear that a dysfunctional immune response leads to the elevated
levels of inflammation in the GI tract. So, is IBD an autoimmune disease? While
it shares similarities with autoimmune diseases, IBD is somewhat different.
Let's dive deeper into IBD, the immune system, and what we know so far.
What is an Autoimmune Disease?
Your immune system
defends you from harmful germs and other potentially dangerous substances in
your environment. It activates when it detects something in the body that it
doesn't recognize as "self," known as an antigen. Once an antigen
is identified, the immune system generates a response to neutralize the
potential threat before it can cause harm.
However, sometimes the immune system malfunctions and
mistakenly attacks healthy tissues, leading to autoimmune
disease. Over 80 autoimmune diseases have been identified, according to the
National Institute of Environmental Health Sciences. Some well-known examples
include:
IBD and the Immune System
IBD
falls under the category of immune-mediated inflammatory diseases (IMIDs).
IMIDs are conditions where chronic inflammation occurs due to an atypical
immune response. Besides IBD, autoimmune diseases are another type of IMID.
Asthma and other allergic conditions can also be classified as IMIDs.
Autoimmune diseases are characterized by an inappropriate
immune response to healthy organs and tissues. For instance, many people with
RA have autoantibodies that attack healthy joint tissue. IBD is a bit
different.
IBD is generally believed to be caused by an abnormal immune
response to environmental triggers in a genetically susceptible person. This
results in chronic inflammation
in the GI tract and the symptoms of IBD, which may include:
- Abdominal pain
- Frequent
diarrhea, which
may contain mucus
or blood
- Unintentional
weight loss
- Fatigue
- Low-grade
fever
What’s Up with the Immune System?
Your GI tract contains many potential antigens, including the
food you eat, some medications, and healthy bacteria known as commensals.
Commensals are crucial
for GI health; they aid digestion and protect your GI tract from harmful
germs. They also play a role in the development of the immune system.
Usually, your immune system tolerates these factors,
recognizing them as harmless and leaving them alone. However, in IBD, a trigger
causes the immune system to mount a response against typically harmless
factors, such as commensals. This leads to persistent inflammation in the
affected part of the GI tract.
In IBD, the lining of the GI tract becomes compromised.
Immune cells flood into the area in an effort to eliminate what is mistakenly
seen as a threat, causing further inflammation and damage. An imbalance of
bacteria, called dysbiosis, also occurs in people with IBD. Whether dysbiosis
is a cause or effect of IBD is unknown, but changes in the types of bacteria in
the GI tract can also influence immune activity and inflammation.
Causes of IBD
As mentioned earlier, the exact cause of IBD remains unclear.
It appears to be a complex combination of immune response, genetics, and
environmental factors. Let's explore genetics and environmental factors
further.
Genetics
Your individual genetics can predispose you to developing
IBD. A 2019 research review notes that first-degree relatives of people with
IBD can have up
to a five times greater risk of developing IBD themselves. This means that
if a close family member, like a parent or sibling, has IBD, you may be at an
increased risk of developing it yourself.
Researchers have identified several genes associated with
IBD. Many of these genes are related to processes important for the development
of chronic inflammation in the GI tract, including:
- Immune
system regulation
- Maintenance
of the GI tract lining
- Oxidative stress
- Antimicrobial
defenses
Environmental Factors
A 2019
study found that the prevalence of IBD worldwide increased significantly
between 1990 and 2017, with the highest increases in high-income countries like
the United States and the United Kingdom. This suggests that certain
environmental risk factors may trigger or contribute to IBD in genetically
susceptible individuals. Some environmental factors associated with IBD risk
include:
- GI
infections, such as those caused by Campylobacter
or Salmonella
- Certain
types of medications, like antibiotics,
nonsteroidal
anti-inflammatory drugs (NSAIDs), and hormonal
birth control
- Diets
rich in fats,
sugars,
or meat
- Smoking,
particularly for Crohn’s disease
Does IBD Increase the Risk of Autoimmune Disease?
Both IBD and autoimmune diseases are IMIDs. Given their
overlapping mechanisms, could having IBD increase your risk of developing an
autoimmune disease? While more studies are needed, some research suggests that
having IBD does increase the risk of autoimmune diseases.
For instance, a 2016 study found that individuals with IBD
had a higher incidence of autoimmune diseases compared to those without IBD.
Severe IBD was associated with a higher risk of developing autoimmune diseases.
Similarly, a 2017 study found that 20 different IMIDs were more common in
people with IBD, including:
- Type
1 diabetes
- RA
- Psoriasis
- Celiac
disease
- Asthma
Treatment and Management of IBD
The goal of IBD treatment is to reduce inflammation in the GI
tract, maintaining remission and preventing disease progression. Medications
are often a critical part of IBD treatment. Several types of medications may be
used, including:
- Aminosalicylates: Drugs like mesalamine
and sulfasalazine
reduce inflammation in the lining of the intestines.
- Corticosteroids: Medications like prednisone
help control inflammation but are typically used for short-term relief due
to potential side effects.
- Immunosuppressant
Drugs: These
include azathioprine
and 6-mercaptopurine, which suppress the immune system to reduce
inflammation.
- Biologics: Medications like adalimumab (Humira) and
infliximab (Remicade)
target specific components of the immune system to prevent inflammation.
Other Interventions for Managing IBD
In addition to medications, other interventions can help
manage IBD, including:
- Bowel
Rest: For
severe Crohn’s disease, a period of bowel rest may be recommended to allow
the intestines to heal.
- Surgery: In some cases, surgery to
remove severely affected parts of the GI tract may be necessary.
- Dietary
Adjustments:
These may include avoiding foods that trigger symptoms, eating smaller
meals more frequently, and using nutritional supplements if you're not
receiving enough nutrients.
The Endnote
IBD is an immune-mediated disease that causes chronic
inflammation in the GI tract. Without treatment, it can continue to damage the
GI tract and lead to serious complications. The exact cause of IBD is still
unknown, but it appears to be caused by an abnormal immune response to an
environmental trigger in genetically predisposed individuals.
Current treatments for IBD focus on reducing inflammation in
the GI tract, which can lead to remission of symptoms. Adhering to your treatment
plan is crucial for maintaining remission and preventing progression of the
disease.
Conclusion
Inflammatory Bowel Disease is a complex condition involving
an abnormal immune response leading to chronic inflammation in the GI tract.
While it shares similarities with autoimmune diseases, IBD is distinct in its
cause and effect. Understanding the intricate relationship between genetics,
environmental factors, and the immune system is key to managing IBD
effectively. By following your treatment plan and making necessary lifestyle
adjustments, you can manage symptoms and improve your quality of life. Always
consult with healthcare professionals for guidance tailored to your specific
needs.
Also Read:
0 Comments